Complexones having the structure of N-2-(azol-1(2)-yl(ethyl-iminodiacetic acids, synthesis, analytical study and biological applications, characterized by their complexing capacity over Ca2+, Mg2+ ions and other bivalent cations, lanthanides and transition metals. In the formula azolN-CH2-CH2-N(CH2-CO2R)2 (I), azol is pirazol; 3,5-dimethylpirazol; indazol; etc. and R is alkyl or H or Na. The compounds having the general formula (I), are obtained by an alkylation reaction of methyl iminodiacetate with N-bromoethylazols and further hydrolysis in acid or basic medium. The process may be modified by alternative synthetic processes which involve N-aminoethylazols as starting materials or the use of cyclization processes in the preparation of N-substituted azol. They can be applied in spectroscopy and nuclear magnetic resonance (NMR) imaging of hydrogen or other nuclei as extrinsic probes of Ca2+, Mg2+ or other metal ions and as contrast agents, in solutions, biological extracts, tissues, entire animals and human beings.
具有 N-2-(azol-1(2)-yl(ethyl-iminodiacetic acids)结构的络合剂的合成、分析研究和
生物应用,其特点是对 Ca2+、Mg2+ 离子和其他二价阳离子、
镧系元素和过渡
金属的络合能力。在式 azolN-
CH2- -N( -CO2R)2 (I) 中,azol 是
吡唑;
3,5-二甲基吡唑;
吲唑等,R 是烷基或 H 或 Na。具有通式(I)的化合物是通过
亚氨基二乙酸甲酯与 N-
溴乙基唑的烷基化反应,并在酸性或碱性介质中进一步
水解得到的。该工艺可通过其他合成工艺进行改良,如将 N-
氨基乙基
偶氮酚作为起始原料,或在制备 N-取代
偶氮酚时使用环化工艺。它们可作为 Ca2+、Mg2+ 或其他
金属离子的外在探针和造影剂,应用于溶液、
生物提取物、组织、整个动物和人体中氢或其他核的光谱学和核磁共振(NMR)成像。